Despite being a mainstay of Parkinson’s disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side-effects with long-term use. A…
Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) such as semaglutide (Ozempic) have recently gained popularity globally, not just for managing type…
